openPR Logo
Press release

Neuropathic Pain Market is projected at a healthy CAGR of 6% between 2019 - 2029

08-09-2022 06:12 AM CET | Health & Medicine

Press release from: Persistence Market Research

Neuropathic Pain Market is projected at a healthy CAGR of 6%

Reaching the revenues of over US$ 6 Bn at the end of 2019, the global neuropathic pain management market is projected for a healthy CAGR during the forecast period (2019 - 2029). Increasing prevalence of neuropathic pain disorders and growing awareness about pain medication are boosting the demand for pain management drugs.

Planning Forward? Access Sample Of Neuropathic Pain Market Report! https://www.persistencemarketresearch.com/samples/4149

Pipeline strategies by manufacturers are focused on introducing advanced drugs with minimum side effects to increase market share. For instance, Pfizer sponsored drug Pregabalin, effective in treating neuropathic (nerve) pain resulting from peripheral nerve trauma that is in phase 3 clinical trials. Increasing research and development activities to develop medications for indications such as post-herpetic neuralgia are creating significant opportunities for manufactures to flourish in the market.

Company Profiles:
• Pfizer Inc.
• Johnson & Johnson Services, Inc.
• Bristol-Myers Squibb Company
• Sanofi S.A
• GlaxoSmithKline plc
• Eli Lilly and Company
• Teva Pharmaceutical Industries Ltd
• Baxter International Inc

How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Neuropathic Pain Market? https://www.persistencemarketresearch.com/methodology/4149

Key Takeaways - Neuropathic Pain Management Market Study
• Attributed to less side effects, tricyclic antidepressant drugs are expected to be popular as compared to opioids and steroids during the forecast period.
• North America is expected to be significant revenue generator owing to emergence of several regional market players and well-developed healthcare infrastructure.
• Retail pharmacies are expected to be dominant distribution channels in the neuropathic pain management market.

Increasing prevalence of diabetic neuropathy and availability of approved neuropathy pain medications have significantly added to the opportunities for market growth, thereby fostering the rate of adoption of neuropathic pain management drugs.

Increasing R&D Spending by Pharmaceuticals Companies Shaping Future
One of the key factors observed to impact the neuropathic pain management market growth is the development of new drugs for treatment of neuropathic and chronic pains. Companies are focusing on clinical trials to develop drugs for efficient treatment of neuropathic pain. For instance, Eli Lilly and Company developed Duloxetine (LY248686) for Diabetic Peripheral Neuropathic Pain (DPNP) that is under phase 4 clinical trial.

At the same time, companies are focused on expanding therapeutic applications of drugs such as opioids and steroids for neuropathic pain management without causing any serious side effects to patients. Currently, more than 100 clinical trials are been carried out for pain management. Among those clinical trials, nearly half of the clinical trials are for various indications of neuropathic pain such as diabetic neuropathy and post-herpetic neuralgia.

Planning To Introduce An Offbeat Product/Technology In The Neuropathic Pain Market? Go To "Purchase Now" To Have Our Neuropathic Pain Market Report! https://www.persistencemarketresearch.com/checkout/4149

What Does the Report Cover?
The neuropathic pain management market, a new study from Persistence Market Research, provides unparalleled insights on evolution of the neuropathic pain management market during 2014 - 2018 and presents demand projections during 2019 - 2029 on the basis of drug class (tricyclic anti-depressants, anticonvulsants, SNRI's, capsaicin cream, local anesthesia, opioids, steroids, and others), indication (diabetic neuropathy, trigeminal neuralgia, post-herpetic neuralgia, chemotherapy-induced peripheral neuropathy and others), distribution channel (retail pharmacies, hospital pharmacies, and online pharmacies) across prominent regions (North America, Latin America, Europe, Asia Pacific and MEA).

Contact Us:
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neuropathic Pain Market is projected at a healthy CAGR of 6% between 2019 - 2029 here

News-ID: 2700857 • Views:

More Releases from Persistence Market Research

Bean Bag Market to Reach US$ 8,496.4 Million by 2032 Driven by Comfort & Lifestyle Trends
Bean Bag Market to Reach US$ 8,496.4 Million by 2032 Driven by Comfort & Lifesty …
The global bean bag market has emerged as a significant segment within the furniture and home décor industry. According to Persistence Market Research, the market generated a revenue of US$ 5,613.4 Million in 2025, reflecting a strong consumer inclination toward comfortable, versatile, and aesthetically appealing seating solutions. The rising popularity of casual living spaces, coupled with increasing disposable income and urbanization, has fueled the adoption of bean bags across residential
Lawn & Garden Watering Equipment Market to Reach US$ 8,805.2 Mn by 2032, Driven by Smart Irrigation Demand
Lawn & Garden Watering Equipment Market to Reach US$ 8,805.2 Mn by 2032, Driven …
Overview of the Market The global lawn and garden watering equipment market is experiencing steady growth, driven by rising consumer demand for efficient and sustainable irrigation solutions. Currently valued at US$ 6,513.8 Mn, the market is projected to reach US$ 8,805.2 Mn by 2032, expanding at a CAGR of 4.4% during the forecast period. The market encompasses a wide range of products, including sprinklers, drip irrigation systems, hose reels, and other
Hotel Gift Card Market to Reach US$ 76.7 Bn in 2025, Driven by Rising Travel & Tourism
Hotel Gift Card Market to Reach US$ 76.7 Bn in 2025, Driven by Rising Travel & T …
The global hotel gift card market is witnessing significant expansion, fueled by the increasing preference for convenient gifting options and the robust growth of the hospitality sector. Estimated at a market size of US$ 76.7 billion in 2025, the market is expected to reach an impressive value of US$ 188.4 billion by 2032, registering a CAGR of 13.7% over the assessment period. The surge in disposable incomes, the growing inclination
Home Fitness Equipment Market to Hit $21.5 Bn by 2032 at 6.2% CAGR Driven by Health Trends
Home Fitness Equipment Market to Hit $21.5 Bn by 2032 at 6.2% CAGR Driven by Hea …
The global home fitness equipment market is witnessing remarkable expansion as consumer lifestyles shift toward health-conscious and convenience-driven habits. Valued at approximately US$ 13.5 billion in 2024, the market is projected to grow at a CAGR of ~6.2% and achieve nearly US$ 21.5 billion by 2032. This steady growth is fueled by rising awareness of fitness, growing prevalence of lifestyle-related diseases, and increasing adoption of at-home workout solutions powered by

All 5 Releases


More Releases for Neuropathic

Neuropathic Pain Management Market Size Analysis by Application, Type, and Regio …
USA, New Jersey- According to Market Research Intellect, the global Neuropathic Pain Management market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period. The neuropathic pain management market is experiencing consistent growth due to rising incidences of chronic conditions such as diabetes, cancer, and neurological disorders, which
Neuropathic Pain Market New Therapeutic Developments and Treatments
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Neuropathic Pain Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including
The increase in Neuropathic Ocular Pain Market Size is a direct consequence of i …
As per DelveInsight, the Neuropathic Ocular Pain Market is anticipated to grow in the coming years owing to the rise in the number of prevalent cases in the 7MM, the improvement in the research and development activities, and the launch of novel therapies in the Neuropathic Ocular Pain market. There are several key players involved in developing therapies for Neuropathic Ocular Pain, like Novartis, and others. The Neuropathic Ocular Pain market
Neuropathic Pain Market Growth Factors and Manufacturers
Neuropathic Pain Market 2022 Global Neuropathic Pain Market to Reach US$ 8.3 Bn by 2024 End. Machine learning and artificial intelligence have been transforming the healthcare vertical since the last few years. AI-powered healthcare solutions are there to help the patients with automation of routine tasks and data analysis. Wearable technologies are a part of exclusive physiotherapy devices that are capable of tracking and analyzing specific movements of the patients. This would
Global Neuropathic Pain Market Research Report Forecast to 2023
Neuropathic Pain Market 2020 comprises a detailed survey of the Neuropathic Pain Market size, share, trends, extension, consumption, and share, segments, application and Forecast 2025. Global "Neuropathic Pain" Market 2020-2025 Report contains all demographic as well as analytical data regarding market review, growth, demand, and budget analysis. The report mainly highlights the significant trends of the Neuropathic Pain market in terms of thriving companies, business methods, product values and pricing, revenue,